China National Medicines Corporation Ltd.
600511
Classificação em ações
#4875
China National Medicines Corporation Ltd., in conjunction with its various... China National Medicines Corporation Ltd., in conjunction with its various operating entities, is a prominent player in the distribution of pharmaceutical goods across China. The enterprise's scope extends to the production and commercialization of innovative as well as pre-existing drug formulations. Additionally, it markets both traditional Chinese patent remedies and modern Western medications, alongside a range of medical apparatus. Complementing these activities, the firm delivers warehousing solutions and acts as an agent for import and export transactions. Its diverse clientele encompasses hospitals, retail pharmacies, and other healthcare organizations. Established in 1999, the company maintains its principal office in Beijing, China.
Preço da ação
$4.02
Valor de mercado
$3.03B
Variação (1 dia)
3.01%
Variação (1 ano)
-0.69%
País
CN
Negociar China National Medicines Corporation Ltd. (600511)
Categoria
Healthcare
Receita da China National Medicines Corporation Ltd. (600511)
Receita em Jun 2026 TTM: $7.76B
De acordo com os últimos relatórios financeiros da China National Medicines Corporation Ltd., a receita atual da empresa (TTM) é $7.76B. Em 2023, a empresa obteve uma receita de $7.02B um aumento em relação a a receita do ano 2022, que foi de $6.60B. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da China National Medicines Corporation Ltd. de 2000 a 2026
Receita no final de cada ano
| Ano | Receita | Alterar |
|---|---|---|
| 2026 (TTM) | $7.76B | 11.97% |
| 2024 | $6.93B | -1.26% |
| 2023 | $7.02B | 6.44% |
| 2022 | $6.60B | -9.78% |
| 2021 | $7.31B | 18.28% |
| 2020 | $6.18B | -3.59% |
| 2019 | $6.41B | 13.84% |
| 2018 | $5.63B | 0.99% |
| 2017 | $5.58B | 11.87% |
| 2016 | $4.99B | 168.02% |
| 2015 | $1.86B | -0.15% |
| 2014 | $1.86B | 12.08% |
| 2013 | $1.66B | 20.63% |
| 2012 | $1.38B | 23.34% |
| 2011 | $1.12B | 24.59% |
| 2010 | $896.61M | 17.84% |
| 2009 | $760.87M | 18.39% |
| 2008 | $642.69M | 31.31% |
| 2007 | $489.45M | 36.11% |
| 2006 | $359.59M | 24.36% |
| 2005 | $289.14M | 32.86% |
| 2004 | $217.63M | 22.35% |
| 2003 | $177.87M | 20.30% |
| 2002 | $147.86M | 0.22% |
| 2001 | $147.54M | 11.05% |
| 2000 | $132.86M | 0.00% |
Receita de empresas similares ou concorrentes
| Empresa | Receita | Diferença de Receita | País |
|---|---|---|---|
| $410.98B | 5,194.83% |
US
|
|
| - | - |
US
|
|
| $254.25B | 3,175.56% |
US
|
|
| - | - |
US
|
|
| $7.64B | -1.55% |
AU
|
